24/7 Market News

Venture Breakfast Bits, by 24/7 Market News

2018-08-23T17:18:45+00:00 Aug. 21, 2018 9:28AM EST|

Venture Market News for August 21, 2018

  • First Patient Enrolled in Delcath Amended Registration Trial in Metastatic Ocular Melanoma

NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the first patient has been enrolled under the amended protocol for its registration trial in ocular melanoma liver metastases. Stanford University Medical Center is the first trial site to enroll a patient under the amended protocol.

Full press release

  • Conversion Labs Reports 208% Q/Q Sales Growth; Profitability Anticipated In Q3

NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB:CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, today reported financial results for the second quarter of 2018 and six months ended June 30, 2018.

Full press release

  • Kush Energy Expands Gas Distribution Facilities into Pacific Northwest

New Facilities to Support Growing Product Demand from Strategic Locations Near Portland and Seattle

GARDEN GROVE, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Kush Bottles, Inc. (OTCQB: KSHB) (“Kush Bottles” or the “Company”), a leading provider of packaging, supplies, vaporizers, hydrocarbon gases, solvents, accessories and branding services for the regulated cannabis industry, today announced the opening of two new hazmat operating facilities strategically located in the Portland, OR and Seattle, WA metropolitan areas, operating under Kush Energy, a division of Kush Bottles. These facilities will focus on supplying customers in these regions with tested, high quality solvents and hydrocarbons which are essential in the cannabis extraction process for the production of items including oils, edibles and waxes

Full press release

  • Biotricity Expands Salesforce to Cover Key US Markets and Begins Advisory Board Expansion to Move Into Preemptive Heart Disease Diagnostics

REDWOOD CITY, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, has expanded its sales team to cover two additional geographic centers in the US that are key to driving faster adoption of its flagship product, Bioflux. The Company has been experiencing great traction with its technology in the marketplace and feels this is the right time to capitalize on its initial momentum and increase its regional footprint. Biotricity is confident that broadening its influence through expansion in high growth sectors will help accelerate sales, drive revenue, and develop market share.

Full press release

  • Future Farm's Florida Subsidiary Prepares for Cultivation with New Hire

Vancouver, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE LLC -- Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQX: FFRMF) announces that its Florida subsidiary, White Sand Nurseries (“WSN”) has hired Jose Sikaffy as Director of Cultivation in preparation for entering the Florida medical cannabis business. Mr. Sikaffy graduated from Valencia College in Orlando and holds a degree in plant science and agriculture technology. He was most recently employed as Cultivation Director of Remeny/Tredwell Nursery, a Florida licensed medical cannabis facility in Eustis.

Full press release

Connect with 24/7 Market News on social media

https://twitter.com/247MarketNewsHQ

https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.

DISCLAIMER:

24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice.   24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

For further information on 24/7 Market News, please go to www.247marketnews.com 

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements

CONTACT:

24/7 Market News

Editor@247marketnews.com

Send this to a friend

Hi, this may be interesting you: Kraig Biocraft Laboratories’ New R&D Facility Extends Its Competitive Advantages and Prepares for Large Scale Production! This is the link: https://www.247marketnews.com/kraig-biocraft-laboratories-new-rd-facility-extends-its-competitive-advantages-and-prepares-for-large-scale-production/